Sickle Cell Disease

Sickle Cell Disease is a hereditary blood disorder characterized by abnormal hemoglobin, the protein in red blood cells that carries oxygen throughout the body. Typically, red blood cells are flexible and round, but in individuals with SCD, they become stiff, sticky, and shaped like sickles or crescent moons. These irregularly shaped cells can get stuck in small blood vessels, leading to various complications.

The hallmark symptom of SCD is pain, which can range from mild to severe and can occur anywhere in the body. Other common symptoms and complications of SCD include: Fatigue (feeling that you are so tired you can’t do the things you want or need to do) Anemia (low red blood cell or hemoglobin) Jaundice (yellowing of the skin and eyes) Fever (elevated temperature that can be a sign of infection)

Common complications of SCD include: Infections Delayed growth and puberty Vision problems Organ damage (e.g., to the spleen, kidneys, lungs) Splenic sequestration Priapism Aplastic Crisis Acute Chest Syndrome Retinopathy Cholestasis Nephropathy Pain Dactylitis

While there is currently no cure for SCD, various treatment options are available to help manage symptoms and complications and improve quality of life for patients. These include: Medications: Patients may be prescribed medications to manage pain, prevent infections, and reduce the risk of complications such as stroke and organ damage. Hydroxyurea is a commonly used medication that can help increase the production of fetal hemoglobin, which can inhibit the formation of sickle-shaped red blood cells. Blood Transfusions: In some cases, patients may require regular blood transfusions to increase the number of normal red blood cells in their bloodstream and reduce the risk of complications. Bone Marrow Transplantation: For select patients, a bone marrow transplant may offer a potential cure for SCD. This procedure involves replacing the patient's diseased bone marrow with healthy donor bone marrow, which can produce normal red blood cells. Gene Therapy: For patients who do not have a matched sibling able to donate their bone marrow for transplant, gene therapy offers a potentially transformative therapy for patients with severe disease. This involves using the patient’s own bone marrow. Bone marrow stem cells are removed from the patient, manipulated so that they make less sickle hemoglobin, and then put back into the patient.

Approximately 100,000 Americans are living with SCD, and millions more worldwide are affected by the disease. SCD is inherited in an autosomal recessive pattern, meaning that both parents must pass must pass on a abnormal Beta globin gene (and at least one must be sickle gene) for an individual to have to disorder. SCD is most commonly found in people of African, Middle Eastern, Mediterranean, and South Asian descent. However, it can affect people of any race or ethnicity.

Education and Awareness: Learn more about SCD, including its causes, symptoms, and treatment options. Stay updated on the latest research and developments in SCD management. Support Services: Connect with a network of individuals, families, and healthcare professionals who understand the challenges of living with SCD. Access resources and support programs to help you navigate the physical, emotional, and practical aspects of the disease. Advocacy: Join us in advocating for policies and initiatives that improve access to quality healthcare, research funding, and support services for those affected by SCD. Together, we can raise our voices and make a difference in the lives of millions.